The elucidation of the early immune system in percutaneous infection of HSV and HIV and the development of novel methods to prevent their cutaneous infection
Project/Area Number |
23390282
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Dermatology
|
Research Institution | University of Yamanashi |
Principal Investigator |
SHIMADA Shinji 山梨大学, 医学工学総合研究部, 教授 (10114505)
|
Co-Investigator(Kenkyū-buntansha) |
KKAWAMURA Tatsuyoshi 山梨大学, 医学部附属病院, 講師 (70262657)
SHIBAGAKI Naotaka 山梨大学, 医学工学総合研究部, 准教授 (40262662)
HARADA Kazutoshi 山梨大学, 医学部附属病院, 講師 (20324197)
|
Project Period (FY) |
2011-04-01 – 2014-03-31
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥19,500,000 (Direct Cost: ¥15,000,000、Indirect Cost: ¥4,500,000)
Fiscal Year 2013: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2011: ¥9,490,000 (Direct Cost: ¥7,300,000、Indirect Cost: ¥2,190,000)
|
Keywords | HSV / HIV / 経皮感染 / ランゲルハンス細胞 / 抗菌ペプチド / 性行為感染症 / 自然免疫 |
Research Abstract |
HSV-2 shedding is associated with increased risk for sexually acquiring HIV. Because Langerhans cells (LCs) are suspected to be the initial target cells infected by HIV following sexual exposure, we studied whether HSV-2 affects HIV infection of LCs. HSV-2 enhanced HIV susceptibility in LCs within skin explants, even though relatively few HSV-2/HIV co-infected LCs were detected, suggesting that HSV-2 enhances HIV infection of LCs through indirect mechanisms. Indeed, HSV-2 stimulated production of antimicrobial peptides (AMPs) by epithelial cells, including human defensins and LL-37, and the latter strongly enhanced HIV susceptibility in LCs by up-regulating HIV receptors. Culture supernatants of epithelial cells infected with HSV-2 enhanced HIV susceptibility in LCs, and this effect was abrogated by blocking LL-37 production. These data suggest that HSV-2 enhances sexual transmission of HIV by increasing HIV susceptibility of LCs via epithelial cell production of LL-37.
|
Report
(4 results)
Research Products
(18 results)
-
-
[Journal Article] Case of primary cutaneous peripheral T-cell lymphoma, not otherwise specified, with characteristics of follicular helper T cells2014
Author(s)
Takaki M, Inozume T, Matsuzawa T, Ando N, Y amaguchi M, Harada K, Kawamura T, Shibagaki N, Shimada S
-
Journal Title
J Dermatol
Volume: (In press)
Issue: 6
Pages: 529-532
DOI
Related Report
Peer Reviewed
-
[Journal Article] EFdA, a reverse transcriptase inhibitor , potently blocks HIV -1 ex vivo infection of Langerhans cells within epithelium2014
Author(s)
Matsuzawa T, Kawamura T, Ogawa Y, Maeda K, Nakata H, Moriishi K, Koyanagi Y, Gatanaga H, Shimada S, Mitsuya H
-
Journal Title
J Invest Dermatol
Volume: 134(4)
Issue: 4
Pages: 1158-61
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Oral administration of the CCR5 inhibitor , maraviroc, blocks HIV ex vivo infection of Langerhans cells within the epithelium2013
Author(s)
Matsuzawa T, Kawamura T, Ogawa Y, Takahashi M, Aoki R, Moriishi K, Koyanagi Y, Gatanaga H, Blauvelt A, Shimada S
-
Journal Title
J Invest Dermatol
Volume: 133(12)
Issue: 12
Pages: 2803-5
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article] Antimicrobial Peptide LL-37 Produced by HSV-2-Infected Keratinocytes Enhances HIV Infection of2013
Author(s)
小川陽一, 川村龍吉, 松澤高光, 青木類, Peter Gee, 山下篤哉, 森石恆司, 山崎研志, 小柳義夫, Andrew Blauvelt, 島田眞路
-
Journal Title
Cell Host & Microbe
Volume: 13
Pages: 77-86
Related Report
Peer Reviewed
-
-
-
-
-
-
-
[Presentation] Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of Langerhans cells2013
Author(s)
小川陽一, 川村龍吉, 松澤高光, 青木類, Peter Gee, 山下篤哉, 森石恆司, 山崎研志, 小柳義夫, Andrew Blauvelt, 島田眞路
Organizer
International Investigative Dermatology
Place of Presentation
エジンバラ国際会議場(エジンバラ, スコットランド)
Related Report
-
-